Ignite Creation Date:
2025-12-25 @ 12:36 AM
Ignite Modification Date:
2026-03-02 @ 4:05 AM
Study NCT ID:
NCT03064867
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2022-11-16
First Post:
2017-02-22
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Venetoclax Plus R-ICE Chemotherapy for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Sponsor:
Molly Gallogly
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CASE2415
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None